Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002309058 | SCV002602867 | likely pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 | 2022-03-17 | criteria provided, single submitter | clinical testing | NM_017739.3(POMGNT1):c.1557delG(K519Nfs*18) is expected to be pathogenic in the context of POMGNT-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in POMGNT1, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |